Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TroVax plus Pemetrexed/Cisplatin in Malignant Pleural Mesothelioma
NCT01569919Phase 2Unknown
- Sponsor
- Wales Cancer Trials Unit
- Start
- Dec 2012
- Primary completion
- Jun 2014
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MVA-5T4 in malignant pleural mesothelioma (MPM), sponsored by Wales Cancer Trials Unit. Status: unknown.
02
Drugs
MVA-5T4
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01569919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01569919.